Brian Stuglik

Director/Board Member at VERASTEM, INC.

Net worth: 1 M $ as of 30/06/2026

66 year

63 connections

Health Technology

Commercial Services

Consumer Services

Profile

Mr. Brian M.
Stuglik is an Independent Director at Puma Biotechnology, Inc., an Independent Director at Oncopeptides AB, a Member at American Association for Cancer Research, a Member at American Society of Clinical Oncology, Inc. and a Member at International Association for the Study of Lung Cancer.
He is on the Board of Directors at Puma Biotechnology, Inc., Oncopeptides AB and Verastem, Inc. Mr. Stuglik was previously employed as a Member by Proventus Health Solutions LLC and a Chief Marketing Officer-Oncology Division & VP by Eli Lilly & Co. He received his undergraduate degree from Purdue University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PUMA BIOTECHNOLOGY, INC. 0.22%	12/06/2026	1,13,858 ( 0.22% )	923 388 $	30/06/2026
VERASTEM, INC. 0.22%	21/05/2026	1,37,147 ( 0.22% )	523 902 $	30/06/2026
ONCOPEPTIDES AB 0.04%	31/12/2024	1,54,828 ( 0.04% )	25 948 $	30/06/2026

Brian Stuglik active positions

Companies	Position	Start
VERASTEM, INC.	Director/Board Member	02/09/2017
ONCOPEPTIDES AB	Director/Board Member	17/05/2018
PUMA BIOTECHNOLOGY, INC.	Director/Board Member	05/07/2020
American Society of Clinical Oncology, Inc. American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services	Corporate Officer/Principal	-
International Association for the Study of Lung Cancer International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a multidisciplinary organization dedicated to the study, research, and eradication of lung cancer and other thoracic malignancies. The non-profit company is based in Aurora, CO. It serves a diverse community including oncologists, thoracic specialists, scientists, patient advocates, and caregivers, advancing lung cancer care through collaborative science, education, advocacy, and clinical practice. IASLC organizes major conferences, supports scientific projects, develops resources for targeted therapy, and publishes journals focused on thoracic oncology. The organization fosters professional development, provides educational materials, policy toolkits, patient advocacy initiatives, and training workshops to improve lung cancer diagnosis, treatment, and prevention.	Corporate Officer/Principal	-
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Corporate Officer/Principal	-

All active positions of Brian Stuglik

Former positions of Brian Stuglik

Companies	Position	End
ELI LILLY AND COMPANY	Corporate Officer/Principal	01/12/2015
Proventus Health Solutions LLC Proventus Health Solutions LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical companies in oncology drug development process	Founder	-

See the detail of Brian Stuglik's experience

Training of Brian Stuglik

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Brian Stuglik's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Eli Lilly & Co. Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products	Health Technology
Purdue University Purdue University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oncopeptides AB Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment	Health Technology
American Society of Clinical Oncology, Inc. American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services	Health Services
American Association for Cancer Research American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Engages in research, education, communication and collaboration to prevent and cure cancer	Commercial Services
International Association for the Study of Lung Cancer International Association for the Study of Lung Cancer Miscellaneous Commercial ServicesCommercial Services The International Association for the Study of Lung Cancer (IASLC) is a multidisciplinary organization dedicated to the study, research, and eradication of lung cancer and other thoracic malignancies. The non-profit company is based in Aurora, CO. It serves a diverse community including oncologists, thoracic specialists, scientists, patient advocates, and caregivers, advancing lung cancer care through collaborative science, education, advocacy, and clinical practice. IASLC organizes major conferences, supports scientific projects, develops resources for targeted therapy, and publishes journals focused on thoracic oncology. The organization fosters professional development, provides educational materials, policy toolkits, patient advocacy initiatives, and training workshops to improve lung cancer diagnosis, treatment, and prevention.	Commercial Services
Verastem, Inc. Verastem, Inc. BiotechnologyHealth Technology Discovers and develops drugs	Health Technology
Puma Biotechnology, Inc. Puma Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a development stage company which develops biopharmaceuticals used for the treatment of cancer	Health Technology
Proventus Health Solutions LLC Proventus Health Solutions LLC Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical companies in oncology drug development process	Commercial Services